The diabetic foot ulcer treatment market size has grown strongly in recent years. It will grow from $7.43 billion in 2024 to $8.02 billion in 2025 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to rising diabetes prevalence, increased awareness and early detection, improved patient education, government initiatives and healthcare policies, multidisciplinary approach to care, wound care guidelines and protocols.
The diabetic foot ulcer treatment market size is expected to see strong growth in the next few years. It will grow to $11.25 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to increasing diabetes awareness campaigns, personalized medicine approaches, patient-centric care models, value-based healthcare initiatives, continuous medical education. Major trends in the forecast period include technological advances in wound care products, multidisciplinary care teams, emphasis on offloading techniques, integration of bioactive dressings, cost-effective and outpatient treatment options, increased use of hyperbaric oxygen therapy.
The diabetic foot ulcer treatment market is poised for growth due to the rising number of diabetes patients. Diabetes, a metabolic illness with long-term effects, significantly contributes to elevated blood glucose levels, leading to substantial harm to various bodily functions. Diabetes is a major cause of foot ulcers, resulting in a heightened demand for effective diabetic foot ulcer treatment. Notably, in 2022, the Centers for Disease Control and Prevention reported around 37.3 million people in the United States suffering from diabetes, comprising 11.3% of the population. Globally, the International Diabetes Federation highlighted approximately 537 million adults with diabetes, emphasizing the considerable impact on both developed and developing countries. The increased prevalence of diabetes is a key factor propelling the growth of the diabetic foot ulcer treatment market.
The diabetic foot ulcer treatment market is set for growth driven by the increasing geriatric population. As individuals aged 65 or older are more susceptible to chronic diseases, including diabetes, cardiovascular issues, and cancer, specialized medical care becomes essential. Elderly individuals, despite comorbidities and dependencies, have a probability of healing from diabetes-related foot ulcers. The World Health Organization predicts a significant rise in the global geriatric population, reaching 1.4 billion individuals aged 60 or older by 2030, doubling to 2.1 billion by 2050. This demographic trend contributes to the growth of the diabetic foot ulcer treatment market as a result of age-related health challenges.
Technological advancement is a significant trend in the diabetic foot ulcer treatment market. Major players in the market are concentrating on innovative technologies, including cloud-based AI technology for the detection of diabetic foot ulcers. For example, in August 2024, Ipca Laboratories, an Indian multinational pharmaceutical company, launched the first-of-its-kind topical gel, Diulcus, specifically for diabetic foot ulcers (DFU) in India. Ipca has priced the Diulcus 15 mg gel at Rs 1365 per pack and will soon distribute it through its extensive network of 4,000 distributors across India.
Major companies in the diabetic foot ulcer treatment market are concentrating on introducing innovative solutions, such as ON101, to gain a competitive advantage. Innovative solutions for diabetic foot ulcer treatment encompass new and advanced methods for managing and healing foot ulcers in individuals with diabetes. For instance, in October 2023, Oneness Biotech Co., a Taiwan-based pharmaceutical firm, launched ON101, a novel cream (brand name Fespixon) designed for the topical treatment of diabetic foot ulcers (DFUs). The ON101 cream is an effective solution for chronic, non-healing DFUs that have not responded to conventional therapies. Clinical trial results show that the wound-healing cream is beneficial for diabetic foot ulcers, with participants reporting a 60% complete healing rate over 16 weeks, surpassing the 35% healing rate observed with absorbent wound dressings.
In August 2023, Coloplast, a Denmark-based company that creates products and services for individuals with medical conditions, acquired Kerecis for an undisclosed amount. Following the acquisition, both companies are collaborating to enhance and broaden the availability of innovative solutions for patients suffering from diabetic foot ulcers. Their combined product offerings present various wound care approaches, providing healthcare professionals with a wider range of options to address the specific needs of their patients. Kerecis is an Iceland-based company that specializes in treating diabetic foot ulcers using fish skin grafts.
Major companies operating in the diabetic foot ulcer treatment market are Coloplast A/S, Medtronic PLC, Molnlycke Health Care AB, B. Braun Melsungen AG, Medline Industries Inc., ConvaTec Inc., Acelity L.P. Inc., 3M Healthcare, Smith & Nephew PLC, Organogenesis Inc., BSN Medical GMBH, Integra LifeSciences Corporation, Derma Sciences Inc., Advancis Medical, Tissue Regenix Group PLC, MiMedx Group Inc., Kerecis, Human Regenerative Technologies LLC, AOTI Inc., Lohmann & Rauscher International GmbH & Co. KG, Urgo Medical, L&R USA Inc., Misonix Inc., Bioventus, Cellumed Co. Ltd.
North America was the largest region in the diabetic foot ulcer treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diabetic foot ulcer treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the diabetic foot ulcer treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
A diabetic foot ulcer is a skin sore with full-thickness skin loss on the foot, resulting from neuropathic and vascular complications in individuals with diabetes mellitus. These ulcers impede the healing process and increase susceptibility to infections, potentially leading to serious complications, including the need for amputation if not properly addressed. Diabetic foot ulcer treatment aims to prevent, treat, and manage these ulcers in diabetic patients.
The primary types of diabetic foot ulcer treatment include wound care dressings, biologics, therapy devices, antibiotic medications, and other interventions. Wound care dressings are sterile pads used to cover wounds, promoting healing and protecting against further damage. Various types of ulcers are classified as neuropathic ulcers, ischemic ulcers, and neuro-ischemic ulcers, categorized by grades 1 through 5 based on severity. Diabetic foot ulcer treatments are utilized by hospitals, ambulatory surgery centers, and other end-users in the healthcare sector.
The diabetic foot ulcer treatment market research report is one of a series of new reports that provides diabetic foot ulcer treatment market statistics, including diabetic foot ulcer treatment industry global market size, regional shares, competitors with a diabetic foot ulcer treatment market share, detailed diabetic foot ulcer treatment market segments, market trends and opportunities, and any further data you may need to thrive in the diabetic foot ulcer treatment industry. This diabetic foot ulcer treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The diabetic foot ulcer treatment market includes revenues earned by entities by ultrasound therapy, negative pressure wound therapy, and active therapies. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The diabetic foot ulcer treatment market size is expected to see strong growth in the next few years. It will grow to $11.25 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to increasing diabetes awareness campaigns, personalized medicine approaches, patient-centric care models, value-based healthcare initiatives, continuous medical education. Major trends in the forecast period include technological advances in wound care products, multidisciplinary care teams, emphasis on offloading techniques, integration of bioactive dressings, cost-effective and outpatient treatment options, increased use of hyperbaric oxygen therapy.
The diabetic foot ulcer treatment market is poised for growth due to the rising number of diabetes patients. Diabetes, a metabolic illness with long-term effects, significantly contributes to elevated blood glucose levels, leading to substantial harm to various bodily functions. Diabetes is a major cause of foot ulcers, resulting in a heightened demand for effective diabetic foot ulcer treatment. Notably, in 2022, the Centers for Disease Control and Prevention reported around 37.3 million people in the United States suffering from diabetes, comprising 11.3% of the population. Globally, the International Diabetes Federation highlighted approximately 537 million adults with diabetes, emphasizing the considerable impact on both developed and developing countries. The increased prevalence of diabetes is a key factor propelling the growth of the diabetic foot ulcer treatment market.
The diabetic foot ulcer treatment market is set for growth driven by the increasing geriatric population. As individuals aged 65 or older are more susceptible to chronic diseases, including diabetes, cardiovascular issues, and cancer, specialized medical care becomes essential. Elderly individuals, despite comorbidities and dependencies, have a probability of healing from diabetes-related foot ulcers. The World Health Organization predicts a significant rise in the global geriatric population, reaching 1.4 billion individuals aged 60 or older by 2030, doubling to 2.1 billion by 2050. This demographic trend contributes to the growth of the diabetic foot ulcer treatment market as a result of age-related health challenges.
Technological advancement is a significant trend in the diabetic foot ulcer treatment market. Major players in the market are concentrating on innovative technologies, including cloud-based AI technology for the detection of diabetic foot ulcers. For example, in August 2024, Ipca Laboratories, an Indian multinational pharmaceutical company, launched the first-of-its-kind topical gel, Diulcus, specifically for diabetic foot ulcers (DFU) in India. Ipca has priced the Diulcus 15 mg gel at Rs 1365 per pack and will soon distribute it through its extensive network of 4,000 distributors across India.
Major companies in the diabetic foot ulcer treatment market are concentrating on introducing innovative solutions, such as ON101, to gain a competitive advantage. Innovative solutions for diabetic foot ulcer treatment encompass new and advanced methods for managing and healing foot ulcers in individuals with diabetes. For instance, in October 2023, Oneness Biotech Co., a Taiwan-based pharmaceutical firm, launched ON101, a novel cream (brand name Fespixon) designed for the topical treatment of diabetic foot ulcers (DFUs). The ON101 cream is an effective solution for chronic, non-healing DFUs that have not responded to conventional therapies. Clinical trial results show that the wound-healing cream is beneficial for diabetic foot ulcers, with participants reporting a 60% complete healing rate over 16 weeks, surpassing the 35% healing rate observed with absorbent wound dressings.
In August 2023, Coloplast, a Denmark-based company that creates products and services for individuals with medical conditions, acquired Kerecis for an undisclosed amount. Following the acquisition, both companies are collaborating to enhance and broaden the availability of innovative solutions for patients suffering from diabetic foot ulcers. Their combined product offerings present various wound care approaches, providing healthcare professionals with a wider range of options to address the specific needs of their patients. Kerecis is an Iceland-based company that specializes in treating diabetic foot ulcers using fish skin grafts.
Major companies operating in the diabetic foot ulcer treatment market are Coloplast A/S, Medtronic PLC, Molnlycke Health Care AB, B. Braun Melsungen AG, Medline Industries Inc., ConvaTec Inc., Acelity L.P. Inc., 3M Healthcare, Smith & Nephew PLC, Organogenesis Inc., BSN Medical GMBH, Integra LifeSciences Corporation, Derma Sciences Inc., Advancis Medical, Tissue Regenix Group PLC, MiMedx Group Inc., Kerecis, Human Regenerative Technologies LLC, AOTI Inc., Lohmann & Rauscher International GmbH & Co. KG, Urgo Medical, L&R USA Inc., Misonix Inc., Bioventus, Cellumed Co. Ltd.
North America was the largest region in the diabetic foot ulcer treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diabetic foot ulcer treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the diabetic foot ulcer treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
A diabetic foot ulcer is a skin sore with full-thickness skin loss on the foot, resulting from neuropathic and vascular complications in individuals with diabetes mellitus. These ulcers impede the healing process and increase susceptibility to infections, potentially leading to serious complications, including the need for amputation if not properly addressed. Diabetic foot ulcer treatment aims to prevent, treat, and manage these ulcers in diabetic patients.
The primary types of diabetic foot ulcer treatment include wound care dressings, biologics, therapy devices, antibiotic medications, and other interventions. Wound care dressings are sterile pads used to cover wounds, promoting healing and protecting against further damage. Various types of ulcers are classified as neuropathic ulcers, ischemic ulcers, and neuro-ischemic ulcers, categorized by grades 1 through 5 based on severity. Diabetic foot ulcer treatments are utilized by hospitals, ambulatory surgery centers, and other end-users in the healthcare sector.
The diabetic foot ulcer treatment market research report is one of a series of new reports that provides diabetic foot ulcer treatment market statistics, including diabetic foot ulcer treatment industry global market size, regional shares, competitors with a diabetic foot ulcer treatment market share, detailed diabetic foot ulcer treatment market segments, market trends and opportunities, and any further data you may need to thrive in the diabetic foot ulcer treatment industry. This diabetic foot ulcer treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The diabetic foot ulcer treatment market includes revenues earned by entities by ultrasound therapy, negative pressure wound therapy, and active therapies. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Diabetic Foot Ulcer Treatment Market Characteristics3. Diabetic Foot Ulcer Treatment Market Trends and Strategies4. Diabetic Foot Ulcer Treatment Market - Macro Economic Scenario Including the Impact of Interest Rates, Inflation, Geopolitics, and the Recovery from COVID-19 on the Market32. Global Diabetic Foot Ulcer Treatment Market Competitive Benchmarking and Dashboard33. Key Mergers and Acquisitions in the Diabetic Foot Ulcer Treatment Market34. Recent Developments in the Diabetic Foot Ulcer Treatment Market
5. Global Diabetic Foot Ulcer Treatment Growth Analysis and Strategic Analysis Framework
6. Diabetic Foot Ulcer Treatment Market Segmentation
7. Diabetic Foot Ulcer Treatment Market Regional and Country Analysis
8. Asia-Pacific Diabetic Foot Ulcer Treatment Market
9. China Diabetic Foot Ulcer Treatment Market
10. India Diabetic Foot Ulcer Treatment Market
11. Japan Diabetic Foot Ulcer Treatment Market
12. Australia Diabetic Foot Ulcer Treatment Market
13. Indonesia Diabetic Foot Ulcer Treatment Market
14. South Korea Diabetic Foot Ulcer Treatment Market
15. Western Europe Diabetic Foot Ulcer Treatment Market
16. UK Diabetic Foot Ulcer Treatment Market
17. Germany Diabetic Foot Ulcer Treatment Market
18. France Diabetic Foot Ulcer Treatment Market
19. Italy Diabetic Foot Ulcer Treatment Market
20. Spain Diabetic Foot Ulcer Treatment Market
21. Eastern Europe Diabetic Foot Ulcer Treatment Market
22. Russia Diabetic Foot Ulcer Treatment Market
23. North America Diabetic Foot Ulcer Treatment Market
24. USA Diabetic Foot Ulcer Treatment Market
25. Canada Diabetic Foot Ulcer Treatment Market
26. South America Diabetic Foot Ulcer Treatment Market
27. Brazil Diabetic Foot Ulcer Treatment Market
28. Middle East Diabetic Foot Ulcer Treatment Market
29. Africa Diabetic Foot Ulcer Treatment Market
30. Diabetic Foot Ulcer Treatment Market Competitive Landscape and Company Profiles
31. Diabetic Foot Ulcer Treatment Market Other Major and Innovative Companies
35. Diabetic Foot Ulcer Treatment Market High Potential Countries, Segments and Strategies
36. Appendix
Executive Summary
Diabetic Foot Ulcer Treatment Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on diabetic foot ulcer treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for diabetic foot ulcer treatment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The diabetic foot ulcer treatment market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) by Treatment: Wound Care Dressings; Biologics; Therapy Devices; Antibiotic Medications; Other Treatments2) by Ulcer Type: Neuropathic Ulcers; Ischemic Ulcers; Neuro-Ischemic Ulcers
3) by Grade: Grade 1; Grade 2; Grade 3; Grade 4; Grade 5
4) by End-User: Hospital; Ambulatory Surgery Centre; Other End-Users
Subsegments:
1) by Wound Care Dressings: Hydrogels; Foam Dressings; Alginates; Antimicrobial Dressings2) by Biologics: Growth Factors; Skin Substitutes; Cellular Therapies
3) by Therapy Devices: Negative Pressure Wound Therapy (NPWT) Devices; Electrical Stimulation Devices; Hyperbaric Oxygen Therapy Devices
4) by Antibiotic Medications: Topical Antibiotics; Systemic Antibiotics
5) by Other Treatments: Debridement Procedures; Compression Therapy; Offloading Devices
Key Companies Mentioned: Coloplast a/S; Medtronic PLC; Molnlycke Health Care AB; B. Braun Melsungen AG; Medline Industries Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
Some of the major companies featured in this Diabetic Foot Ulcer Treatment market report include:- Coloplast A/S
- Medtronic PLC
- Molnlycke Health Care AB
- B. Braun Melsungen AG
- Medline Industries Inc.
- ConvaTec Inc.
- Acelity L.P. Inc.
- 3M Healthcare
- Smith & Nephew PLC
- Organogenesis Inc.
- BSN Medical GMBH
- Integra LifeSciences Corporation
- Derma Sciences Inc.
- Advancis Medical
- Tissue Regenix Group PLC
- MiMedx Group Inc.
- Kerecis
- Human Regenerative Technologies LLC
- AOTI Inc.
- Lohmann & Rauscher International GmbH & Co. KG
- Urgo Medical
- L&R USA Inc.
- Misonix Inc.
- Bioventus
- Cellumed Co. Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | February 2025 |
| Forecast Period | 2025 - 2029 |
| Estimated Market Value ( USD | $ 8.02 Billion |
| Forecasted Market Value ( USD | $ 11.25 Billion |
| Compound Annual Growth Rate | 8.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 26 |
